CREDIT AGREEMENT dated as of February 28, 2014 among ENDO LIMITED, ENDO MANAGEMENT LIMITED, ENDO LUXEMBOURG HOLDING COMPANY S.À R.L., ENDO LUXEMBOURG FINANCE COMPANY I S.À R.L., ENDO LLC (FORMERLY KNOWN AS NIMA ACQUISITION, LLC), The Lenders Party...Credit Agreement • February 28th, 2014 • Endo International PLC • Pharmaceutical preparations
CREDIT AGREEMENT (this “Agreement”) dated as of February 28, 2014, among ENDO LIMITED, a company duly incorporated under the laws of the Republic of Ireland (Registered Number 534651) (the “Irish Holdco”), Endo Management Limited, a company duly incorporated under the laws of the Republic of Ireland (Registered Number 538432) (the “Irish Sub Holdco”), Endo Luxembourg Holding Company S.à r.l., a société à responsabilité limitée (private limited liability company) incorporated under the laws of Luxembourg, having its registered office at 65, boulevard Grande-Duchesse Charlotte, L-1331 Luxembourg, with a share capital of USD 17,000 and registered with the Luxembourg Register of Commerce and Companies under number B182517 (“Lux Holdco”), Endo Luxembourg Finance Company I S.à r.l., a société à responsabilité limitée (private limited liability company) incorporated under the laws of Luxembourg, having its registered office at 65, boulevard Grande-Duchesse Charlotte, L-1331 Luxembourg, with a
SUPPLEMENTAL INDENTURESupplemental Indenture • February 28th, 2014 • Endo International PLC • Pharmaceutical preparations • New York
AMENDED AND RESTATED INDENTURE dated as of February 28, 2014 among ENDO FINANCE LLC, a Delaware limited liability company (the “Issuer”), ENDO FINCO INC., a Delaware corporation (the “Co-Obligor”), the Guarantors (as defined herein) and WELLS FARGO BANK, NATIONAL ASSOCIATION, a national banking association, as trustee (the “Trustee”).
FIRST SUPPLEMENTAL INDENTUREFirst Supplemental Indenture • February 28th, 2014 • Endo International PLC • Pharmaceutical preparations • New York
This First Supplemental Indenture (“First Supplemental Indenture”) is made as of February 28, 2014, by and among Endo Health Solutions Inc. (formerly known as Endo Pharmaceuticals Holdings Inc.), a corporation duly organized under the laws of Delaware, as issuer (the “Issuer”), Endo International plc (formerly known as Endo International Limited), a company incorporated in the Republic of Ireland, as co-obligor (the “Co-Obligor”), and The Bank of New York Mellon (formerly named The Bank of New York), a New York banking corporation, as Trustee (the “Trustee”) under the Indenture referred to below.
